Responses to parliamentary questions
Question from Deputy Ken O’Flynn - PQ 38847-26
Deputy O'Flynn asked about the reimbursement consideration for omaveloxolone (skyclarys). Read the HSE response.
From: Communications and public affairs
Published: May 2026
Updated: July 2026
Documents
Question from Deputy Ken O’Flynn - PQ 38847-26
PDF, 469KB, 3 pages
Summary
To ask the Minister for Health if any budget impact assessment, cost projection, prevalence estimate, or epidemiological model was prepared in advance of reimbursement consideration for omaveloxolone (skyclarys); and the details of same.
This is a beta version - your feedback will help us to improve it